Association of β2-adrenoreceptor variants with bronchial hyperresponsiveness

被引:53
|
作者
Ulbrecht, M
Hergeth, MT
Wjst, M
Heinrich, J
Bickeböller, H
Wichmann, HE
Weiss, EH
机构
[1] Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Epidemiol, Oberschleissheim, Germany
[3] Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany
关键词
D O I
10.1164/ajrccm.161.2.9902072
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Because of its involvement in the regulation of airway tone, the beta(2)-adrenoreceptor is considered a candidate for bronchial hyperresponsiveness (BHR) associated with asthma. This notion is supported by several reports that have implicated the chromosomal region 5q31-q33 harboring the gene for the beta(2)-adrenoreceptor in the genetics of asthma and related phenotypes. We performed a population-based association study focusing on BHR as a qualitative trait and omitting other asthma-related phenotypes. From a German population sample of 1,150 individuals we extracted all 152 bronchohyperreactive probands, who were compared with 295 bronchonormoreactive control subjects. All individuals were genotyped for three single nucleotide polymorphisms of the beta(2)-adrenoreceptor gene resulting in variants at the amino acid positions 16, 27, and 164. The genotyping protocol used allowed the determination of haplotypes of these polymorphisms. Whereas no individual polymorphism was associated with BHR, the Gly16/Gln27/Th164 haplotype was significantly underrepresented in the case group indicating a protective effect of this haplotype with regard to BHR. Upon reanalysis by sex a significant association persisted only for female probands.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 50 条
  • [1] Association of β2-adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness
    Kim, SH
    Oh, SY
    Oh, HB
    Kim, YK
    Cho, SH
    Kim, YY
    Min, KU
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (04) : 630 - 635
  • [2] Association of β2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD
    Umeda, Nobuaki
    Yoshikawa, Takahiro
    Kanazawa, Hiroshi
    Hirata, Kazuto
    Fujimoto, Shigeo
    RESPIROLOGY, 2008, 13 (03) : 346 - 352
  • [3] β2-adrenoreceptor polymorphisms and asthma
    Wjst, Matthias
    LANCET, 2006, 368 (9537): : 710 - 711
  • [4] Association of polymorphisms in the β2-adrenoreceptor gene with higher levels of parasitic infection
    Ramsay, CE
    Hayden, CM
    Tiller, KJ
    Burton, PR
    Hagel, I
    Palenque, M
    Lynch, NR
    Goldblatt, J
    LeSouëf, PN
    HUMAN GENETICS, 1999, 104 (03) : 269 - 274
  • [5] Association of polymorphisms in the β2-adrenoreceptor gene with higher levels of parasitic infection
    Claire E. Ramsay
    Catherine M. Hayden
    Katrina J. Tiller
    Paul R. Burton
    Isabel Hagel
    Miguel Palenque
    Neil R. Lynch
    Jack Goldblatt
    Peter N. LeSouëf
    Human Genetics, 1999, 104 : 269 - 274
  • [6] (-)-Formoterol, a selective β2-adrenoreceptor agonist
    Yamanouchi Pharmaceutical Co, Ltd, Ibaraki, Japan
    Acta Crystallogr Sect C Cryst Struct Commun, pt 12 ([d]1887-1889):
  • [7] (-)-formoterol, a selective β2-adrenoreceptor agonist
    Kurihara, H
    Fujita, S
    Mase, T
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1997, 53 : 1887 - 1889
  • [8] No association between human β2-adrenoreceptor gene polymorphism and obesity or type 2 diabetes
    Hedenbro, JL
    Carlsson, M
    Orho, M
    Groop, LC
    DIABETOLOGIA, 1998, 41 : A112 - A112
  • [9] Rational design of new α2-adrenoreceptor agonists
    Gentili, Francesco
    Cardinaletti, Claudia
    Carrieri, Antonio
    Ghelfi, Francesca
    Giannella, Mario
    Piergentili, Alessandro
    Quaglia, Wilma
    Vesprini, Cristian
    Pigini, Maria
    DRUGS OF THE FUTURE, 2007, 32 : 82 - 82
  • [10] Attenuation of Choroidal Neovascularization by β2-Adrenoreceptor Antagonism
    Lavine, Jeremy A.
    Sang, Yanzhi
    Wang, Shoujian
    Ip, Michael S.
    Sheibani, Nader
    JAMA OPHTHALMOLOGY, 2013, 131 (03) : 376 - 382